OTHER CURRENT CLINICAL TRIALS (Including Dystonia, Pseudobulbar Affect (PBA) and Ultrasound Studies):
2005-Present: A longitudinal study of the variable phenotypic presentations of Rapid-Onset Dystonia Parkinsonism and other movement disorders, Investigator Initiated, Allison Brashear, MD
Jared Cook, MS, email@example.com, (336) 716-9007
2012-Present: Dystonia Coalition Projects, Sponsors: NIH: National Institute of Neurological Disorders and Stroke and Office of Rare Disease Research
Janet Hutchens, BS, CCRC, firstname.lastname@example.org, (336) 716-1715
2013-Present: A study evaluating the efficacy and safety of DYSPORT in patients with Cervical Dystonia, Sponsor: Ipsen
2013-Present: A study assessing the long term efficacy and safety of DYSPORT in patients with Cervical Dystonia, Sponsor: Ipsen
Charlotte Miller, RN, CCRC, email@example.com, (336) 716-9056
Allison Brashear, MD is the Principal Investigator for all the clinical trials listed above.
2013-Present: A Study to Assess the Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA), Sponsor: Avanir Pharmaceuticals
Sara Vaughan, BA, CCRC, firstname.lastname@example.org, (336) 716-8694
Mustafa Siddiqui, MD is the Principal Investigator for the PBA clinical trial.
2010-Present: A study on the establishment of reference values for neuromuscular ultrasound in extremes of population, Investigator Initiated, Michael Cartwright, MD
Jessica Bargoil, email@example.com, (336) 716-3919
Michael Cartwright, MD is the Principal Investigator for the Ultrasound study